// App-Quantinova.ai

OP.4A.11 : THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION

Researchers

Presenter

  • Brugts, J

Principal Investigators

  • Bertrand, M

  • Remme, W

  • Ferrari, R

  • Fox, K

  • Macmahon, S

  • Chalmers, J

  • Simoons, M

  • Boersma, E

Medical Centers

  • Erasmus MC Thoraxcentre, Rotterdam, The Netherlands

  • Lille Heart Institute, Lille, France

  • Sticares Research, Rhoon, The Netherlands

  • Azienda Ospedaliero-Universitaria, Udine, Italy

  • The Royal Marsden Hospital, London, United Kingdom

Locations

  • Netherlands

  • France

  • Italy

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Perindopril

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved